Literature DB >> 23051933

Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.

Andrew Davenport1.   

Abstract

BACKGROUND/AIMS: Both brain natriuretic peptide (BNP) and volume overload are reported to be powerful predictors of survival for peritoneal dialysis patients. The usefulness of single BNP determinations in helping determine volume status in peritoneal dialysis patients remains controversial, so we reviewed serial BNP and multifrequency bioimpedance measurements to determine whether changes in BNP reflected changes in volume status.
METHODS: Prospective measurements of fluid volume by multifrequency bioimpedance and serum N-terminal pro-BNP (NTproBNP) were conducted in stable adult peritoneal dialysis outpatients attending for routine assessments of peritoneal dialysis adequacy and transport status.
RESULTS: A total of 189 serial measurements were made in 92 patients, and NTproBNP increased from a median of 162.5 pmol/l (interquartile range 82-385.4) to 195 pmol/l (interquartile range 101.9-348.6; p < 0.05). Changes in NTproBNP correlated with changes in extracellular water (ECW), total body water (TBW) and ECW/TBW (r = 0.38, 0.31 and 0.45, respectively; all p < 0.0001). Patients were divided into quartiles depending upon NTproBNP changes; those with the greatest fall in NTproBNP had significant falls in ECW (p < 0.001), TBW (p = 0.001) and ECW/TBW (p < 0.001) compared to the quartile with the greatest increase in NTproBNP, who also had an increase in systolic blood pressure from 133.5 ± 22.7 to 142.7 ± 28.8 mm Hg (p = 0.0078), whereas it fell in the quartile with the greatest fall in NTproBNP (143.8 ± 24.6 vs. 136.5 ± 18.7 mm Hg).
CONCLUSIONS: Serial measurements of NTproBNP correlated with changes in volume assessments made by multifrequency bioimpedance in peritoneal dialysis outpatients. As multifrequency bioimpedance measures total ECW, rather than effective plasma volume, serial NTproBNP determinations may prove an adjunct to the clinical assessment of volume status in peritoneal dialysis patients.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051933     DOI: 10.1159/000343286

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

1.  Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?

Authors:  Andrew Davenport; Banwari Argawal; Gavin Wright; Konstantinos Mantzoukis; Rumyana Dimitrova; Joseph Davar; Panayota Vasianopoulou; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2013-08-27

2.  Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids.

Authors:  Monika Lichodziejewska-Niemierko; Michał Chmielewski; Maria Dudziak; Alicja Ryta; Bolesław Rutkowski
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

Review 3.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

4.  Peritoneal protein clearance rather than faster transport status determines outcomes in peritoneal dialysis patients.

Authors:  Gayathri Rajakaruna; Ben Caplin; Andrew Davenport
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

5.  Temporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.

Authors:  Matthew A Roberts; David L Hare; Ken Sikaris; Francesco L Ierino
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

6.  Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues.

Authors:  Evangelina Charitaki; Andrew Davenport
Journal:  J Nephrol       Date:  2014-01-29       Impact factor: 3.902

7.  Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement.

Authors:  Haiyan Chen; Buyun Wu; Dehua Gong; Zhihong Liu
Journal:  Crit Care       Date:  2015-04-02       Impact factor: 9.097

8.  Overhydration Negatively Affects Quality of Life in Peritoneal Dialysis Patients: Evidence from a Prospective Observational Study.

Authors:  Hye Eun Yoon; Young Joo Kwon; Ho Cheol Song; Jin Kuk Kim; Young Rim Song; Seok Joon Shin; Hyung Wook Kim; Chang Hwa Lee; Tae Won Lee; Young Ok Kim; Byung Soo Kim; Kyoung Hyoub Moon; Yoon Kyung Chang; Seong Suk Kim; Kitae Bang; Jong Tae Cho; Sung Ro Yun; Ki Ryang Na; Yang Wook Kim; Byoung Geun Han; Jong Hoon Chung; Kwang Young Lee; Jong Hyeok Jeong; Eun Ah Hwang; Yong-Soo Kim
Journal:  Int J Med Sci       Date:  2016-08-11       Impact factor: 3.738

9.  Factors associated with systolic hypertension in peritoneal dialysis patients.

Authors:  Surachet Vongsanim; Andrew Davenport
Journal:  J Nephrol       Date:  2019-08-10       Impact factor: 3.902

10.  The Impact of Volume Overload on the Longitudinal Change of Adipose and Lean Tissue Mass in Incident Chinese Peritoneal Dialysis Patients.

Authors:  Jack Kit-Chung Ng; Gordon Chun-Kau Chan; Kevin Ka-Ho Kam; Na Tian; Win Hlaing Than; Phyllis Mei-Shan Cheng; Man-Ching Law; Wing-Fai Pang; Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.